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bstract
The use of patient-reported outcome measures (PROMs) is set to rise in physiotherapy. PROMs provide additional ‘patient-centred’ data
hich is unique in capturing the patient’s own opinion on the impact of their disease or disorder, and its treatment, on their life. Thus, PROMs
re increasingly used by clinicians to guide routine patient care, or for the purposes of audit, and are already firmly embedded in clinical
esearch. This article seeks to summarise the key aspects of PROM use for physiotherapists, both in routine clinical practice and in the research
etting, and highlights recent developments in the field. Generic and condition-specific PROMs are defined and examples of commonly used
easures are provided. The selection of appropriate PROMs, and their effective use in the clinical and research settings is discussed. Finally,
xisting barriers to PROM use in practice are identified and recent physiotherapy PROM initiatives, led by the Royal Dutch Society for
hysical Therapy are explored. 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
icenses/by-nc-nd/4.0/).
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Patient-reported outcome measures (PROMs) have been
ollected in the NHS since 2009 and look set to pro-
oundly change the face of modern healthcare delivery
1]. PROMs are increasingly used by clinicians to guide
nd audit routine care, and are already firmly embed-
ed in clinical research. These important patient-centred
easures are likely to have a growing impact on physio-herapists, in the UK and internationally. Patient-reported
utcome research findings will increasingly guide policy
akers and clinicians in providing evidence-based treatment.
∗ Corresponding author. Tel.: +44 01782 733900; fax: +44 01782 733911.
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icenses/by-nc-nd/4.0/).n addition, the routine clinical use of PROMs may allow
hysiotherapists to more effectively track treatment impact,
hus aiding the development of optimal management strate-
ies. Indeed, the Chartered Society of Physiotherapy (CSP)
ctively encourages such an approach, stating: ‘Physiothera-
ists must be able to demonstrate measurable improvements
n the clinical outcomes of their patients as part of daily
ractice.’[2]. The use of PROMs to measure health sta-
us in routine practice has some distinct advantages over
raditional research-based outcome measures, as they may
irectly facilitate change behaviour for patients, clinicians,
anagers and policymakers. Widespread adoption of PROMs
cross physiotherapy is therefore something for the profes-
ion to embrace as it has the potential to empower patients,
upport clinical decision-making and drive forward quality
mprovement.
ss article under the CC BY-NC-ND license (http://creativecommons.org/
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This article seeks to summarise the key aspects of PROM
se for physiotherapists, both in routine clinical practice and
n the research setting, and highlights recent developments in
he field.
hat  are  PROMs?
Patient-reported outcomes measures (PROMs) are defined
s: ‘.  . . any report of the status of a patient’s health condition
hat comes directly from the patient, without interpretation
f the patient’s response by a clinician or anyone else.’[3].
ROM information can be gathered using paper-based or
lectronic questionnaires. Their use in clinical practice helps
o ensure the patient ‘voice’ is present in all aspects of
are, which is essential to ensure therapeutic management
emains patient-centred [4]. PROMs capture patient’s own
pinions on the impact of their condition, and its treatment,
n their life. Questionnaires are therefore usually designed
o focus on one or more specific elements of a patient’s well-
eing. Some PROMs specifically measure a combination of
hysical, mental and social aspects, collectively known as
ealth-related quality of life (HRQL), while others evaluate
ingle dimensions of health, for example, physical activ-
ty [5]. The specific questions within a PROM (known as
items’) are usually grouped together to form appropriate
ub-categories, or ‘domains’. For example, several questions
egarding ambulation may be grouped within the domain
mobility’. Patient’s answers in these sub-categories provide
ndividual domain scores, which are often combined to gen-
rate an overall PROM score. Scoring methods vary between
ROMs, however, so it is important to carefully check each
nstrument’s instructions.
PROMs can be broadly categorised as either generic or
ondition-specific instruments [6]: this distinction is impor-
ant. Generic PROMs measure the wellbeing of all types of
atients, regardless of their illness or disorder. Thus, they
re particularly useful for comparing outcomes at the  group,
r aggregate  level. For example, the EQ-5D [7] is a com-
on generic PROM recommended by the CSP as a standard
easure for out-patient MSK physiotherapy practice [2]. Its
onsistent use across therapy services will allow local and
ational comparisons with other providers and with the gen-
ral population.
Generic PROMs may not always provide a sufficient level
f detail or responsiveness for measuring change in a single
atient over time, however. In this instance, physiotherapists
hould also consider utilising a condition-specific PROM.
hese measures focus on a particular disease or disorder and
ddress the most relevant concerns for a target population; an
xample is the Neck Disability Index [8]. Condition-specific
ROMs tend to be more responsive to subtle changes in the
atient’s condition, and are therefore better suited to measur-
ng outcomes at the  individual  level.
A third category of PROMs which has gained attention
n research and practice, are individualised instruments such
r
p
c
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s the Patient Generated Index [9], Patient Specific Func-
ion Scale [10] or the MYMOP [11]. Individualised measures
xamine patients’ own definition of health related quality of
ife and challenge the prevailing approach of pre-definition
f the outcomes being measured by researchers and clini-
ians. Their particular value is for goal setting and monitoring
rogress at a highly individual level, which tends to make
hem more sensitive to change than conventional measures.
owever, policy makers tend not to favour the use of indivi-
ualised instruments in isolation, they are therefore typically
sed in combination with other types of PROMs.
ommon  PROMs  in  physiotherapy  research  and
outine practice
PROMs are increasingly collected in physiotherapy
esearch, usually as secondary outcomes in clinical trials,
ften accompanying a more objective ‘clinical’ primary
utcome. Recent examples include the ‘mirror therapy for
atients with severe arm paresis after stroke’ trial [12], which
sed a generic PROM to measure independence in activities
f daily living (the Barthel Index), alongside a condition-
pecific measure of quality of life in stroke patients (the
troke Impact Scale). These secondary outcomes were col-
ected alongside a primary outcome, measured using an
bjective physical test (the Fugl–Meyer Assessment), which
valuated functional upper limb recovery. This use of both
bjective and patient-reported trial outcomes is now common
nd ensures that trials better capture information regarding
spects of recovery that are important to patients. Further
xamples are presented in Table 1.
The use of PROMs in routine UK physiotherapy practice
s less well established, but is increasing as part of the wider
uality improvement agenda driven by the commissioners of
ervices [13]. Physiotherapy providers are therefore being
sked to use PROMs to evidence the quality of their care,
longside other metrics such as safety and patient experi-
nce data. Significantly the CSP included PROMs in their
012 ‘Any Qualified Provider’ (AQP) national specification
or musculoskeletal physiotherapy [14]. Since then the use of
ROMs has been extended for wider monitoring by commis-
ioners and also as a contract requirement for many private
ector health insurers. The CSP has thus promoted the use of
he EuroQol EQ-5D PROM [7] as a routine generic patient
eported outcome measure with extensive take up by the UK
rofession. More recently, the society has started to encour-
ge a combined approach: advocating routine collection of a
eneric PROM alongside both a condition-specific PROM
nd a patient-reported experience measure. The CSP has
lso been working with its professional networks to make
ecommendations for routine PROM collection relating to
articular conditions or pathways of care. To help facilitate
onsistency and best practice in PROM data collection, the
SP has recently set up a health informatics team to provide
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Table 1
PROMs in selected recent physiotherapy trials.
Study Subject PROMs
Brovold T, Skelton DA, Bergland A. Older adults
recently discharged from the hospital: effect
of aerobic interval exercise on health-related
quality of life, physical fitness, and physical
activity. J Am Geriatr Soc 2013;61:1580–5
The effect of aerobic interval exercise on
health-related quality of life, physical fitness,
and physical activity in older adults recently
discharged from the hospital
Medical outcomes study 36-item short form
survey (SF-36)a,c
Physical activity scale for the elderly
(PASE)b,d
Cross JL, Elender F, Barton G, Clark A,
Shepstone L, Blyth A, et al. Evaluation of the
effectiveness of manual chest physiotherapy
techniques on quality of life at six months
post exacerbation of COPD (MATREX): a
randomised controlled equivalence trial. BMC
Pulm Med 2012;12:33
Effectiveness of manual chest physiotherapy
techniques on quality of life at six months
post exacerbation of COPD
Saint Georges respiratory questionnairea,d
Cuesta-Vargas AI, Gonzalez-Sanchez M,
Casuso-Holgado MJ. Effect on health-related
quality of life of a multimodal physiotherapy
program in patients with chronic
musculoskeletal disorders. Health Qual Life
Outcomes 2013;11:19
Effect on health-related quality of life of a
multimodal physiotherapy programme in
patients with chronic musculoskeletal
disorders
Short form-12 health survey (SF-12)a,c
EuroQoL-5Db,c
Visual analogue scale (VAS)b,c
Kjeken I, Bo I, Ronningen A, Spada C,
Mowinckel P, Hagen KB, et al. A three-week
multidisciplinary in-patient rehabilitation
programme had positive long-term effects in
patients with ankylosing spondylitis:
randomized controlled trial. J Rehabil Med:
Off J UEMS Eur Board Phys Rehabil Med
2013;45:260–7
Long-term effects of a three-week
multidisciplinary in-patient rehabilitation
programme for patients with ankylosing
spondylitis
Bath Ankylosing Spondylitis Disease
Activity Scale (BASDAI)a,d
Bath Ankylosing Spondylitis Functional
Index (BASFI)a,d
Medical outcomes study 36-item short form
survey (SF-36)b,c
Kromer TO, de Bie RA, Bastiaenen CH.
Physiotherapy in patients with clinical signs
of shoulder impingement syndrome: a
randomized controlled trial. J Rehabil Med:
Off J UEMS Eur Board Phys Rehabil Med
2013;45:488–97
Physiotherapy in patients with clinical signs
of shoulder impingement syndrome
Shoulder pain and disability indexa,d
Patient’s global impression of changea,c
Weekly pain scoreb,c
Generic patient-specific scaleb,c
Patients’ satisfaction with treatmentb,c
Ruta D, Garratt AM, Leng M, Russell IT,
MacDonald LM. A new approach to the
measurement of quality of life: the patient
generated index. Med Care 32;1109–26
Mirror therapy for patients with severe arm
paresis after stroke
Barthel indexb,c
Stoke impact scaleb,d
van Nimwegen M, Speelman AD, Overeem S,
van de Warrenburg BP, Smulders K, Dontje
ML, et al. Promotion of physical activity and
fitness in sedentary patients with Parkinson’s
disease: randomised controlled trial. BMJ
2013;346:f576
Promotion of physical activity and fitness in
sedentary patients with Parkinson’s disease
LASA physical activity questionnaire
(LAPAQ)a,c
Activity diaryb,c
Parkinson’s disease questionnaire
(PDQ-39)b,d
Abbreviations: PROMs, patient-reported outcome measures.
a Primary outcome.
b Secondary outcome.
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d Condition-specific measure.
eadership in this rapidly changing environment and further
nformation is available at www.csp.org.uk/proms.
electing  an  ‘appropriate’  PROM
When searching for an appropriate PROM, it is first impor-
ant to ask the following questions: (a) ‘what do I want to
easure?’; (b) ‘what is the rationale for assessment?’; and
c) ‘at what level will the measurement take place (group or
ndividual)?’ For clinicians wanting to benchmark the per-
ormance of their service it is also increasingly important to
b
t
psk (d) ‘what PROMs are recommended and being used by
thers?’ The first question will help determine which health
omain(s) should be utilised, e.g., pain, mobility, social func-
ioning, etc. Consideration should also be given to capturing
he most relevant health domains for the target population.
he second, third and fourth questions will aid selection of
he appropriate tool. For instance, to measure differences in
ain between patient groups in a trial, in a way that would be
asily generalisable to the population, a generic PROM may
e most appropriate [6]. If, on the other hand, one wished
o measure the same changes in a single patient with knee
ain, in order to inform decisions about ongoing treatment, a
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ensitive condition-specific measure may be the best option
15]. Of course, it may be appropriate and optimal to use a
eneric, and condition-specific PROM and/or a patient gener-
ted scale in combination [16]. Whatever the final selection, it
hould be underpinned with a clear understanding of the ulti-
ate purpose of outcome measurement in the given context,
o ensure the right tool is selected for the job.
PROMs should also be selected based on the strength of
heir measurement properties (i.e., reliability, validity and
esponsiveness), which should be established in the popu-
ation of interest, and also on other key aspects including
cceptability and interpretability. Reliability encompasses:
est-retest reliability, or the degree to which results are repli-
ated over time in stable patients; internal consistency, how
ell items that are grouped in a particular domain correlate;
nd, in interviewer administered PROMs, inter-rater reliabil-
ty, i.e., agreement between two independent interviewers
17]. Validity encompasses: content validity, or the degree
o which the PROM evaluates all important aspects of the
isease/disorder; construct validity, whether behaviour of the
easure is consistent with hypotheses regarding: (a) probable
elationships with other instruments and/or (b) performance
f the tool in different subgroups; and criterion validity, i.e.,
orrelation with a ‘gold standard’ [17]. Some measures are
etter than others in their ability to discriminate between indi-
iduals with different levels of severity at a single point in
ime, and some are better than others in their responsiveness,
hich is their ability to detect change within individuals over
ime [17]. PROMs should also be acceptable to their target
opulation, both in terms of the questions asked (e.g., are
hey appropriately worded?) and their overall patient burden
e.g., is the completion time for the PROM agreeable?) [15].
easures must also be easily interpretable, i.e., the meaning
f differences in PROM score should be clearly understood
18].
There are a number of resources available to aid both
ocation and selection of validated PROMs. The Patient-
eported Outcome and Quality of life Instruments Database
PROQOLID; www.proqolid.org) [19] can be searched for
pecific instruments (e.g., ‘Neck Disability Index’) or by dis-
ase/disorder (e.g., ‘osteoarthritis’), or domain (e.g., ‘pain’).
he International Society for Quality of Life Research
ISOQOL) has published recommendations on the agreed
inimum measurement property standards for PROMs
20]. Finally, the COnsensus-based Standards for the selec-
ion of health Measurement INstruments (COSMIN) group
ave produced a critical appraisal checklist (available at
ww.cosmin.nl) for the evaluation of PROM measurement
roperties [17,18,21].
sing  PROMs  in  researchBefore commencing a research study, one should ensure
hat each PROM is validated in the population under study,
ypically in a longitudinal or cross-sectional study or as part
l
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sy 101 (2015) 119–125
f a clinical trial [5,22]. If not, a validation process will need
o be factored in to the design of the project (see Coyne
t al. [22] for details). As mentioned above, the instrument
hould possess adequate measurement properties, respon-
iveness, acceptability and interpretability. In addition, it is
ital to include comprehensive details surrounding the col-
ection of PROM data in the study protocol, this will help
aximise the quality of the data, and is especially important
here PROM assessment might take place across multiple
esearch sites [23]. In particular, plans for the prevention
f missing PROM data (either individual items or whole
uestionnaires) should be routinely included as this can be a
ommon problem [24]. Local guidelines regarding the inclu-
ion of PROM information in protocols are available [25] and
nternational consensus guidelines are in development [26].
inally, a CONSORT (Consolidated Standards of Reporting
rials) PRO checklist has been developed to assist researchers
n reporting patient-reported outcome trial results [27].
sing  PROMs  in  clinical  practice
PROMs can assist physiotherapists in their clinical rea-
oning process for diagnosis and treatment, with a specific
ocus on the patient’s perspective. Involving the patient in this
ay can also help stimulate self-management [28]. PROMs
an also be used by the physiotherapist, in concert with the
atient, to identify the main problems in functioning and
ctivities in daily living. Thus, PROMs can assist in estab-
ishing treatment objectives and monitor treatment results.
hen using PROMs for monitoring purposes, however, phy-
iotherapists should be aware questionnaire data will likely
ncorporate a degree of measurement error at the individ-
al patient level. Therefore it is important to be aware of
he PROMs Minimal Clinically Important Change Score
MCID), defined as the smallest difference in PROM domain
core which patients may perceive to be beneficial and which
s ‘significant enough to change patient management’ [29].
hose PROMs that have been developed for use at the group
evel in research settings (especially generic tools) may be
ess reliable at the individual patient level [30], therefore,
ROM measurement should always be used as an adjunct to
linical judgement.
arriers  to  PROM  use
Clinicians widely recognise the potential use of PROMs
or improving the process of care by enhancing commu-
ication, patient education, shared-decision making and
onitoring response to treatment. However, several barri-
rs to the use of PROMs have been identified, which could
essen their usefulness in informing important health care
ecisions. Boyce and colleague’s [31] review of qualitative
tudies investigating the experiences of healthcare profes-
ionals using PROMs identified practical barriers including:
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he absence of a PROM collection infrastructure and the
dditional staff burden from PROM measurement that was
disruptive to normal work duties’ [32]. Similarly, a system-
tic review undertaken by allied health professionals, outlined
 number of potential obstacles to routine outcome mea-
urement, including: the absence of effective PROM-specific
rganisational and peer-support; and a lack of knowledge
nd confidence about using outcome measures [33]. These
ndings highlight the importance of having efficient PROM
ollection systems, as well as training staff involved in imple-
enting the process.
Several studies have identified the added value of PROMs
n improving the communication between clinicians and
atients and for detecting health problems that would other-
ise have gone unnoticed [34]. However, systematic reviews
hat assess the effectiveness of PROMs feedback on patient-
utcomes show that the impact of such interventions is
ariable [34,35]. Effectiveness appears to be related to the
unction of the PROM, with the highest impact associated
ith the use of PROMs as management tools in outpatient
ettings for a specialised patient population; while the evi-
ence for use of generic PROMs was less conclusive [35].
his research highlights the importance of having a target
opulation in mind, with clear goals in place, to ensure routine
ROM collection delivers the maximum benefit for patient
are.
he  use  of  PROMs  for  benchmarking
PROMs data have been introduced for service evalua-
ion and commissioning of care in several countries. The
ational Health Service (NHS) in England introduced the
outine collection of PROMs data in 2009, using the EQ-5D
s generic questionnaire alongside other condition-specific
uestionnaires to collect data before and after elective sur-
ical procedures including total hip and knee replacements
36]. In the Netherlands, PROMs data are being collected by
urchasers of care for accountability purposes in combination
ith patient experience measures [37]. While international
ase studies illustrate the use of PROM data in clinical
ractice settings and implementation at health system level
or performance measurement, these efforts have not yet
emonstrated the feasibility of integrating the use of PROMs
n a wide scale [38].
The use of PROMs at group level for quality improvement
r performance measurement has received little attention in
he literature. A recent systematic review found only one
tudy that assessed peer-comparison feedback for improving
atient functional status, and found no statistical differences
etween intervention and control groups [35]. The effective-
ess of public reporting of PROMs data has also not yet
een studied. However, indirect evidence for the effective-
ess of public reporting of performance measures suggests
hat quality improvement activities of healthcare practitioners
ncrease based on public report cards [39,40].
t
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The use of PROMs data for performance measurement
rovides unique methodological challenges. First, the PROM
tself should be valid and reliable for measuring treatment
esults at patient level. Second, the performance measure
s derived from the PROM data should be valid and reli-
ble to identify practice variation and quality of healthcare
roviders. Third, data should be reported and presented in an
nambiguous manner to support commissioners and patients
n making informed choices [41–43]. Advanced methodol-
gy is needed to enhance interpretation of data in comparing
he quality of providers to inform patients and purchasers.
ased on emerging evidence, guidance and research efforts
o improve the interpretability of patient-reported outcomes
s likely to enhance decision-making and the impact from
sing PROMs in practice.
ROMs:  recent  directions
The Royal Dutch Society for Physical Therapy (KNGF)
as established a national four-year programme to stimulate
he use of PROMs in clinical practice and provide perfor-
ance measurement. In a series of pilot projects PROMs are
eing tested for their added value in supporting physiother-
pists and patients in decision-making. A national database
as been established for aggregating data at the group level
o measure the results and quality of physiotherapy services.
ata will be fed back to physiotherapists for quality improve-
ent purposes, and the validity and reliability of data for
eveloping performance measures will be tested. The cur-
ent focus of the programme is the use of PROMs in primary
are practice for five main patient groups (low back pain,
eck pain, hip and knee problems, and shoulder complaints).
ROMs will also be tested for several chronic conditions such
s peripheral artery disease.
In the UK, ideas for a similar programme are still in
heir infancy but are being discussed within the CSP. Under-
inning research is required to develop methods to enable
uture benchmarking of physiotherapy services using PROM
ata and the provision of national normative PROM change
cores. At present, data describing the variability of clinical
utcomes and costs among physiotherapy services is lack-
ng. To enable future fair comparisons, methods are required
o enable the standardisation of PROMs information using
ppropriate adjustment for local case-mix (e.g., deprivation,
ge and ethnicity) and to ensure PROMs data is able to iden-
ify variability in performance.
onclusion
Within UK physiotherapy, PROMs are making a rapid
ransition from their traditional home within research to real-
ife busy clinical practice. The main driver for this change
ppears to be the political context and the demands of
ommissioners for evidence of the quality of care services
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rovide. There are several key messages for physiotherapists
ishing to utilise PROMs. For clinicians, it is important that
ROMs are selected carefully, to ensure they realise their
otential in playing a direct role in assisting clinical reason-
ng, management and shared decision-making. It is crucial
hat the tool captures the aspects of health that matter the
ost to the patient population for which they are intended.
or managers there are key messages to ensure the successful
ntegration of PROMs into practice, including the impor-
ance of addressing barriers such as knowledge deficits and
 lack of confidence in using PROMs; and also overcom-
ng the complexity of establishing a culture of routine data
ollection. Finally, for leaders of the profession we high-
ight the urgent need to ensure that appropriate organisational
nd peer-support on this topic is available, which includes
ase examples of best practice, alongside clear guidance on
he choice of PROMs for different conditions relevant to
hysiotherapy practice. We also call for greater funding of
he underpinning research required to enable future bench-
arking and performance comparisons.
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